Targeted Diagnostics & Therapeutics, Inc

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical staging for colorectal cancer. The information derived from this test can assist physicians in making decisions about the administration of chemotherapy to improve disease-free survival. A similar test has been developed for the detection of circulating colorectal cancer cells in blood. This determines that patients undergoing post-operative surveillance for recurrent colorectal cancer remain free of disease. Intensive research and development is being conducted on treating metastatic colorectal cancer with novel therapeutic agents specifically targeted only to those cancer cells.TDT has established procedures to conduct our diagnostic tests on tissue and blood samples supplied from doctors and hospitals throughout the world. These tests are performed in our state-of-the art laboratory facilities in West Chester, PA. The tests can only be ordered by a physician and results are reported directly back to the ordering physician.

Contact Details: 1045 Andrew Drive West Chester Pennsylvania 19380 United States of America Tel: 800-431-0689 Fax: 610-431-0805 Email: mail@tdtinc.com WWW: www.tdtinc.com/

Loading...

BioNews Results for Targeted Diagnostics & Therapeutics, Inc:
Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Mole	KOTA Territory News:  Aug 2 2008 10:34AM Matching: targeted diagnostics
FDA Clears the Pathwork Tissue of Origin Test for Hard-To-Identify Tumors	Pharmalive.com:  Aug 1 2008 9:08AM Matching: targeted diagnostics
Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Mole	KRON4:  Aug 1 2008 5:20PM Matching: targeted diagnostics
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors	KRON4:  Jul 31 2008 3:37PM Matching: targeted diagnostics
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors	KOTA Territory News:  Jul 31 2008 1:30PM Matching: targeted diagnostics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Targeted Diagnostics & Therapeutics, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 160 times since April 2007, the link to the organisation's website has been followed 40 times

Recent Search Terms used to find this page: Targeted Diagnostics Therapeutics, Inc. | diagnocure 1045 ANDREW DR 19380 | targeted diagnostics | Targeted Diagnostics Therapeutics Inc. TDTemail | .

Search for more companies in West Chester

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Targeted Diagnostics & Therapeutics, Inc